AEON Biopharma, Inc. — All Filings
320 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
25
25-NSE
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
ARS/A
CERT
CORRESP
DEF 14A
DEFA14A
DEFM14A
DEFR14A
DEL AM
DRS
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-4MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001837607-25-000050 | May 14, 2025 | Mar 31, 2025 |
| 3 | — | 0001610717-25-000110 | May 1, 2025 | Apr 29, 2025 |
| 4 | — | 0001610717-25-000111 | May 1, 2025 | Apr 29, 2025 |
| ARS | ARS | 0001837607-25-000038 | Apr 29, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0001837607-25-000035 | Apr 29, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001837607-25-000032 | Apr 25, 2025 | Apr 22, 2025 |
| 8-K | 8-K | 0001837607-25-000030 | Apr 21, 2025 | Apr 19, 2025 |
| 8-K | 8-K | 0001837607-25-000027 | Apr 8, 2025 | Apr 3, 2025 |
| 8-K | 8-K | 0001837607-25-000025 | Mar 27, 2025 | Mar 24, 2025 |
| 8-K | 8-K | 0001837607-25-000021 | Mar 24, 2025 | — |
| 10-K | 10-K | 0001837607-25-000022 | Mar 24, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001837607-25-000015 | Mar 10, 2025 | — |
| SCHEDULE 13G | — | 0001213900-25-021962 | Mar 10, 2025 | — |
| SCHEDULE 13D/A | — | 0001104659-25-021722 | Mar 7, 2025 | — |
| SCHEDULE 13G | — | 0001137439-25-000157 | Mar 3, 2025 | — |
| UPLOAD | — | 0000000000-25-002324 | Feb 28, 2025 | — |
| 8-K | 8-K | 0001837607-25-000013 | Feb 24, 2025 | — |
| SCHEDULE 13G/A | — | 0001140361-25-004892 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001326389-25-000109 | Feb 14, 2025 | — |
| 8-K | 8-K | 0001837607-25-000010 | Feb 7, 2025 | Feb 3, 2025 |
| DEF 14A | DEF 14A | 0001837607-25-000007 | Jan 23, 2025 | Feb 24, 2025 |
| SCHEDULE 13D | — | 0001104659-25-005235 | Jan 22, 2025 | — |
| PRE 14A | PRE 14A | 0001837607-25-000005 | Jan 13, 2025 | Feb 24, 2025 |
| SCHEDULE 13G | — | 0001079973-25-000056 | Jan 13, 2025 | — |
| SCHEDULE 13G | — | 0001079973-25-000061 | Jan 13, 2025 | — |
| SCHEDULE 13G | — | 0000921895-25-000092 | Jan 8, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-001665 | Jan 7, 2025 | Jan 6, 2025 |
| 424B5 | 424B5 | 0001104659-25-001515 | Jan 7, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-001109 | Jan 6, 2025 | — |
| 424B5 | 424B5 | 0001104659-25-000991 | Jan 6, 2025 | — |
| 8-K | FORM 8-K | 0001104659-24-130805 | Dec 20, 2024 | Dec 18, 2024 |
| SC 13G | SC 13G | 0001140361-24-046966 | Nov 14, 2024 | — |
| 424B3 | 424B3 | 0001837607-24-000094 | Nov 13, 2024 | — |
| 8-K | 8-K | 0001837607-24-000092 | Nov 13, 2024 | — |
| 10-Q | 10-Q | 0001837607-24-000093 | Nov 13, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001837607-24-000085 | Oct 7, 2024 | — |
| 4/A | OWNERSHIP DOCUMENT | 0001104659-24-098707 | Sep 10, 2024 | Aug 31, 2024 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-097067 | Sep 4, 2024 | Aug 31, 2024 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-097060 | Sep 4, 2024 | Aug 31, 2024 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-097061 | Sep 4, 2024 | Aug 31, 2024 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-097062 | Sep 4, 2024 | Aug 31, 2024 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-097064 | Sep 4, 2024 | Aug 31, 2024 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-097065 | Sep 4, 2024 | Aug 31, 2024 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-097059 | Sep 4, 2024 | Aug 31, 2024 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-097066 | Sep 4, 2024 | Aug 31, 2024 |
| 424B5 | 424B5 | 0001104659-24-091622 | Aug 21, 2024 | — |
| EFFECT | — | 9999999995-24-002598 | Aug 21, 2024 | — |
| CORRESP | — | 0001104659-24-091144 | Aug 20, 2024 | — |
| UPLOAD | — | 0000000000-24-009482 | Aug 19, 2024 | — |
| S-3 | S-3 | 0001104659-24-089800 | Aug 15, 2024 | — |